Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease - ScienceDirect mardi 2 janvier 2018 à 11:20 via https://news.ycombinator.com/item?id=16048069 — Permalink